Search - tctmd.com

Displaying 121 - 140 of 458

$Treatment of Refractory In-Stent Restenosis State-of-the-Art Review: From Standard Approaches to Parental Drugs and Vascular Brachytherapy$

Presentation TCT 2017

Treatment of Refractory In-Stent Restenosis State-of-the-Art Review: From Standard Approaches to Parental Drugs and Vascular Brachytherapy

Presenter: Robert A. Byrne, Ran Kornowski, Ron Waksman

October 30, 2017

News Conference News TCT 2017

DARE Supports Drug-Coated Balloon as Alternative to DES for Any In-Stent Restenosis

Todd Neale

October 30, 2017

Presentation TCT 2017

Treatment of First-time In-Stent Restenosis State-of-the-Art Review: From Lesion Preparation and Imaging to Restenting to DCB

Presenter: Robert A. Byrne, Ran Kornowski, Fernando Alfonso

October 30, 2017

Presentation TCT 2017

Does DCB Technology Have an Important Role in Treatment of De Novo Coronary Artery Disease? If Not Today, Tomorrow?

Presenter: Robert A. Byrne, Ran Kornowski, Bernardo Cortese

October 30, 2017

Presentation TCT 2017

Drug-Coated Coronary Balloon Therapy: Current State-of-the-Art

Presenter: Robert A. Byrne, Ran Kornowski, Bruno Scheller

October 30, 2017

Presentation TCT 2017

PLLA-Based Biolimus A9 Elution II: From Nobori to Ultimaster Specifications and Results

Presenter: Ioannis Iakovou, Gert Richardt, Shigeru Saito

October 30, 2017

Presentation TCT 2017

Complex PCI in Triple Vessel Disease: Do the Economics Make Sense?

Presenter: Fernando Alfonso, Patrick W. Serruys, Hemal Gada

October 30, 2017

Presentation TCT 2017

Hungary Presents: How I Treated This Complex CTO

Presenter: Valeri L Gelev, Michael Kang-Yin Lee, Stefan Mot, Zoltan Ruzsa

October 30, 2017

Presentation TCT 2017

PLLA-Based Biolimus A9 Elution I: Outcomes With the BioMatrix Family of DES

Presenter: Ioannis Iakovou, Gert Richardt, Christophe Dubois

October 30, 2017

Presentation TCT 2017

Hong Kong Presents: How Should I Treat This Complex CTO?

Presenter: Valeri L Gelev, Michael Kang-Yin Lee, Stefan Mot, Zoltan Ruzsa, Li-Wah Tam

October 30, 2017

Presentation TCT 2017

PCI vs. CABG: The Impact of Medication Adherence on Comparative Outcomes

Presenter: Fernando Alfonso, Patrick W. Serruys, Paul Kurlansky

October 30, 2017

Presentation TCT 2017

Hungary Presents: My Worst Complication During a CTO PCI

Presenter: Valeri L Gelev, Michael Kang-Yin Lee, Stefan Mot, Zoltan Ruzsa

October 30, 2017

Presentation TCT 2017

The Orsiro Sirolimus-eluting Stent: Outcomes From the BIOFLOW and BIORESORT Trials

Presenter: Ioannis Iakovou, Gert Richardt, Clemens von Birgelen

October 30, 2017

Presentation TCT 2017

Hong Kong Presents: Management of Complications During CTO PCI

Presenter: Valeri L Gelev, Michael Kang-Yin Lee, Stefan Mot, Zoltan Ruzsa

October 30, 2017

Presentation TCT 2017

SYNTAX II: Contemporary Outcomes of PCI in 3VD

Presenter: Fernando Alfonso, Patrick W. Serruys, Adrian P. Banning

October 30, 2017

Presentation TCT 2017

MiStent and DESSOLVE III Outcomes: Are the Stent and Clinical Trial Results Unique?

Presenter: Ioannis Iakovou, Gert Richardt, Robert J. de Winter

October 30, 2017

Presentation TCT 2017

Hong Kong Presents: How I Treated This Complex CTO

Presenter: Valeri L Gelev, Michael Kang-Yin Lee, Stefan Mot, Zoltan Ruzsa, Li-Wah Tam

October 30, 2017

Presentation TCT 2017

Do We Have Enough Data to Make PCI vs CABG Decisions in Complex CAD Using FFR?

Presenter: Fernando Alfonso, Patrick W. Serruys, William F. Fearon

October 30, 2017

Presentation TCT 2017

Hungary Presents: How Should I Treat This Complex CTO?

Presenter: Valeri L Gelev, Michael Kang-Yin Lee, Stefan Mot, Zoltan Ruzsa

October 30, 2017

Presentation TCT 2017

Expanding Clinical Evidence With SYNERGY: From EVOLVE II to Real-world Registries and EVOLVE DAPT

Presenter: Ioannis Iakovou, Gert Richardt, Dean J. Kereiakes

October 30, 2017

Advertisement

Treatment of Refractory In-Stent Restenosis State-of-the-Art Review: From Standard Approaches to Parental Drugs and Vascular Brachytherapy

DARE Supports Drug-Coated Balloon as Alternative to DES for Any In-Stent Restenosis

Treatment of First-time In-Stent Restenosis State-of-the-Art Review: From Lesion Preparation and Imaging to Restenting to DCB

Does DCB Technology Have an Important Role in Treatment of De Novo Coronary Artery Disease? If Not Today, Tomorrow?

Drug-Coated Coronary Balloon Therapy: Current State-of-the-Art

PLLA-Based Biolimus A9 Elution II: From Nobori to Ultimaster Specifications and Results

Complex PCI in Triple Vessel Disease: Do the Economics Make Sense?

Hungary Presents: How I Treated This Complex CTO

PLLA-Based Biolimus A9 Elution I: Outcomes With the BioMatrix Family of DES

Hong Kong Presents: How Should I Treat This Complex CTO?

PCI vs. CABG: The Impact of Medication Adherence on Comparative Outcomes

Hungary Presents: My Worst Complication During a CTO PCI

The Orsiro Sirolimus-eluting Stent: Outcomes From the BIOFLOW and BIORESORT Trials

Hong Kong Presents: Management of Complications During CTO PCI

SYNTAX II: Contemporary Outcomes of PCI in 3VD

MiStent and DESSOLVE III Outcomes: Are the Stent and Clinical Trial Results Unique?

Hong Kong Presents: How I Treated This Complex CTO

Do We Have Enough Data to Make PCI vs CABG Decisions in Complex CAD Using FFR?

Hungary Presents: How Should I Treat This Complex CTO?

Expanding Clinical Evidence With SYNERGY: From EVOLVE II to Real-world Registries and EVOLVE DAPT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content